Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
150Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $2.38M | $478.6K | $0.02 |
| 2023 | $2.46M | $852.0K | $0.03 |
| 2022 | $1.92M | $191.3K | $0.01 |
| 2021 | $931.0K | $-485.0K | $-0.02 |
| 2017 | $456.00M | $-194.00M | $-4.14 |
Social Signal Score
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.03
- Implied price
- $0.48
- Return from $0.39
- 4.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.24 — -37.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.0% | -12.4% | -8.4% | -5.0% | -2.1% | 0.6% |
| 3.0% | -8.0% | -3.8% | -0.2% | 2.9% | 5.7% |
| 8.0% | -3.5% | 0.9% | 4.6% | 7.9% | 10.8% |
| 13.0% | 1.0% | 5.6% | 9.5% | 12.9% | 16.0% |
| 18.0% | 5.4% | 10.2% | 14.3% | 17.9% | 21.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (6)
- Newsnewsfilecorp.com·1d ago·Neutral
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH New York, New York--(Newsfile Corp. - August 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28,…
View source ↗ - Newsglobenewswire.com·1d ago·Neutral
…GNIZED INVESTOR RIGHTS COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff d…
View source ↗ - Newsprnewswire.com·3d ago·Neutral
PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.
View source ↗ - Newsnewsfilecorp.com·3d ago·Neutral
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH New York, New York--(Newsfile Corp. - August 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 2
View source ↗ - Newsnewsfilecorp.com·6d ago·Neutral
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28,
View source ↗ - Newsglobenewswire.com·7d ago·Neutral
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”). A class action
View source ↗